IRIS
LARUSSA, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.600
AS - Asia 1.112
EU - Europa 715
SA - Sud America 173
AF - Africa 17
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 3.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.535
SG - Singapore 458
CN - Cina 295
IT - Italia 241
BR - Brasile 137
DE - Germania 135
IN - India 124
GB - Regno Unito 106
VN - Vietnam 82
FI - Finlandia 69
SE - Svezia 56
CA - Canada 44
IR - Iran 38
NL - Olanda 25
HK - Hong Kong 22
TR - Turchia 19
AR - Argentina 16
RU - Federazione Russa 14
MX - Messico 13
TW - Taiwan 11
AU - Australia 10
FR - Francia 10
PL - Polonia 10
BD - Bangladesh 9
ID - Indonesia 8
UA - Ucraina 8
IQ - Iraq 7
EC - Ecuador 6
RO - Romania 6
UZ - Uzbekistan 6
ES - Italia 5
IL - Israele 5
PY - Paraguay 5
ZA - Sudafrica 5
AT - Austria 4
CL - Cile 4
EU - Europa 4
PH - Filippine 4
PK - Pakistan 4
SA - Arabia Saudita 4
AL - Albania 3
CZ - Repubblica Ceca 3
JP - Giappone 3
LT - Lituania 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AO - Angola 2
BE - Belgio 2
BH - Bahrain 2
CH - Svizzera 2
CU - Cuba 2
EG - Egitto 2
HU - Ungheria 2
JM - Giamaica 2
LB - Libano 2
PS - Palestinian Territory 2
RS - Serbia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
QA - Qatar 1
VE - Venezuela 1
Totale 3.634
Salva come PNG Salva come JPEG
Città #
San Jose 292
Ashburn 152
Chandler 152
Singapore 143
Munich 114
Dallas 106
Chicago 90
London 86
Santa Clara 84
Hefei 79
Bengaluru 77
Lawrence 68
Princeton 68
Milan 66
Beijing 53
Helsinki 47
Wilmington 41
Ho Chi Minh City 31
Catanzaro 30
Ottawa 30
Des Moines 21
Hong Kong 20
São Paulo 20
Hanoi 19
Redwood City 19
Mumbai 18
Los Angeles 14
Turku 14
Mendicino 12
Shanghai 11
Guangzhou 10
New York 10
Istanbul 9
Praia A Mare 9
Rome 9
Boardman 8
Phoenix 8
The Dalles 8
Collegeville 7
Orem 7
Pune 7
Tehran 7
Chennai 6
Cittanova 6
Redmond 6
Shenzhen 6
Warsaw 6
Brooklyn 5
Council Bluffs 5
Curitiba 5
Da Nang 5
Hanover 5
Jyväskylä 5
Montreal 5
Norwalk 5
Rio de Janeiro 5
San Francisco 5
Belo Horizonte 4
Boston 4
Brasília 4
Clearwater 4
Horia 4
Miami 4
Santo André 4
Selargius 4
Silea 4
Taipei 4
Bade District 3
Bari 3
Benevento 3
Bratislava 3
Buffalo 3
Campinas 3
Cape Town 3
Charlotte 3
Dhaka 3
Frankfurt am Main 3
Fremont 3
Jiaxing 3
Kahramanmaraş 3
Karachi 3
Mexico City 3
Miguel Hidalgo 3
Nanjing 3
Naples 3
Paris 3
Quito 3
Rende 3
Riyadh 3
San Juan 3
Stockholm 3
São Bernardo do Campo 3
Tashkent 3
Tel Aviv 3
Vienna 3
Wuxi 3
Zabki 3
Amsterdam 2
Ankara 2
Ann Arbor 2
Totale 2.292
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 248
Dietary polyphenolsand non-alcoholic fatty liver disease 106
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 94
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 79
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 78
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 74
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 73
The role of gluten-free diet in nonalcoholic fatty liver disease development 73
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 72
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 68
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 64
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 64
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 63
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 63
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 61
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 60
Gut microbiota and non-alcoholic fatty liver disease 59
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 57
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 56
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 55
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 55
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 53
Decreased circulating interleukin-33 concentration in Helicobacter pylori-infected patients with peptic ulcer: Evaluation of its association with a cytokine gene polymorphism, gender of patients and bacterial virulence factor CagA 53
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 51
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 51
Bone mineralization in celiac disease 51
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients 47
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 47
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 47
Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients 46
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 46
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial 45
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients 44
Effect of selective cyclooxygenase (COX)-2 inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 44
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study 44
Crohn disease: Identification, diagnosis, and clinical management. 44
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 43
Reduced bone mineral density is frequent in treated adult coeliac disease not with standing complete normalization of duodenal lesions. 43
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori 43
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers 42
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers 41
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 40
Epidemiology of Helicobacter pylori infection: the Sorbo San Basile study. 39
Survey on alcohol consumption in a gastroenetrology outpatient center in southern Italy. 39
Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: a cross-sectional study 38
Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. 38
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 37
Normal Bone Mineral Density Associates with Duodenal Mucosa Healing in Adult Patients with Celiac Disease on a Gluten-Free Diet 37
Living with inflammatory bowel diseases: patients’ perceptions and unmet needs from a single-center Italian survey 37
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to standard pharmeceutical treatment: a double-blind, randomized, placebo-controlled study 37
Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/Th2 Immune Response in Human Gastric Mucosa 37
High prevalence of polymorphism and low activity of thiopurine methiltransferase in patients with inflammatory bowel disease. 37
Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease 37
Potential role of fecal gluten immunogenic peptides to assess dietary compliance in celiac patients 36
Liver Cirrhosis Complications Management At The Emergency Department 36
Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production. 35
Potential role of nutraceutical compounds in inflammatory bowel disease 35
SURVEY ON ALCOHOL CONSUMPTION IN A GASTROENTEROLOGY OUTPATIENT CENTER IN SOUTHERN ITALY 34
High Exposure, Spontaneous Clearance, and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study 34
T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection 34
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β protein 34
Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa 34
No evidence of circulating autoantibodies against osteoprotegerin in treated celiac patients with low bone mineral density. 33
Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection 33
Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives 32
Liver steatosis in celiac disease: the open door 31
Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey 30
Vitamin D down-regulates the expression of some Th17 cell-related cytokines, key inflammatory chemokines, and chemokine receptors in experimental autoimmune encephalomyelitis 30
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 29
No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease 29
OLEUROPEIN EXERTS ANTIOXIDANT ACTIVITY AND REDUCES THE EXPRESSION OF COX-2 AND PROINFLAMMATORY CYTOKINES IN CACO-2 CELLS AND COLONIC MUCOSA FROM ULCERATIVE COLITIS PATIENTS 29
The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study 29
From Pre- and Probiotics to Post-Biotics: A Narrative Review. 29
Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review 29
High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. 27
Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir 26
Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better 20
Totale 3.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.122
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022258 8 7 14 49 17 4 10 48 22 26 37 16
2022/2023610 138 35 48 41 34 36 7 50 55 96 62 8
2023/2024290 69 20 25 16 10 75 6 15 27 2 9 16
2024/2025884 119 45 43 18 70 121 64 42 159 8 73 122
2025/20261.454 84 185 142 211 188 62 175 105 166 105 28 3
Totale 3.748